Medicare Enrolled
Dr. Julie Lundy, M.D.
Family Medicine · Longview, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lundy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lundy? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lundy
Dr. Julie Lundy is a family medicine in Longview, TX, with 18 years in practice. Based on federal Medicare data, Dr. Lundy performed 8,668 Medicare services across 4,197 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lundy received a total of $9,269 from 52 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lundy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 2% volume in TX$ $9,269 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,668
Medicare services
Top 2% in TX for family medicine
4,197
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~482 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,060 | $18 | $65 |
| Office visit, established patient (30-39 min) | 513 | $75 | $200 |
| Comprehensive metabolic blood panel | 477 | $10 | $105 |
| Blood draw (venipuncture) | 422 | $8 | $20 |
| Lipid panel (cholesterol and triglycerides) | 411 | $13 | $66 |
| Complete blood count (CBC) with differential | 368 | $8 | $40 |
| Thyroid stimulating hormone (TSH) test | 290 | $16 | $70 |
| Hemoglobin A1c test (diabetes monitoring) | 250 | $9 | $60 |
| Chronic care management, first 20 min/month | 222 | $45 | $65 |
| Annual wellness visit, follow-up | 212 | $125 | $130 |
| Vitamin D level test | 201 | $29 | $140 |
| Automated urinalysis | 174 | $2 | $18 |
| Urinalysis with microscopic exam | 166 | $3 | $22 |
| Urine culture, bacterial colony count | 153 | $8 | $35 |
| Screening mammography | 129 | $87 | $300 |
| 3D screening mammography (tomosynthesis) | 126 | $23 | $71 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 114 | $283 | $305 |
| Pneumonia vaccine administration | 114 | $29 | $30 |
| Drug injection, under skin or into muscle | 92 | $9 | $50 |
| Bone density scan (DEXA) | 80 | $30 | $89 |
| Flu vaccine administration | 74 | $30 | $31 |
| Flu vaccine, high-dose | 67 | $72 | $85 |
| Basic metabolic blood panel | 66 | $8 | $59 |
| Antibiotic sensitivity test | 62 | $8 | $40 |
| Urine microalbumin test (kidney screening) | 55 | $6 | $70 |
| Creatinine test (kidney function) | 55 | $5 | $25 |
| Office visit, established patient (20-29 min) | 51 | $57 | $135 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 51 | $29 | $70 |
| Vitamin B-12 level test | 48 | $15 | $77 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 48 | $77 | $150 |
| Urine culture, bacterial identification | 47 | $8 | $20 |
| Iron level test | 45 | $6 | $35 |
| Prostate cancer screening; prostate specific antigen test (psa) | 44 | $19 | $95 |
| Chronic care management, additional 20 min/month | 36 | $36 | $50 |
| Complete ultrasound scan of 1 breast | 28 | $66 | $416 |
| Iron binding capacity test | 26 | $9 | $40 |
| Annual depression screening | 26 | $18 | $20 |
| Limited ultrasound scan of 1 breast | 24 | $35 | $158 |
| Assessment of emotional or behavioral problems | 24 | $4 | $20 |
| Ferritin level test (iron stores) | 23 | $13 | $72 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 23 | $38 | $80 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 23 | $16 | $30 |
| Bacterial culture, aerobic | 21 | $8 | $50 |
| Diagnostic mammography of 1 breast | 18 | $56 | $253 |
| Chest X-ray, 2 views | 17 | $15 | $64 |
| Magnesium level test | 16 | $6 | $24 |
| Uric acid level test | 16 | $4 | $25 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $160 | $252 |
| Transitional care management services for problem of high complexity | 12 | $175 | $410 |
| Folic acid level test | 11 | $14 | $80 |
| Parathyroid hormone level test | 11 | $40 | $280 |
| Electrocardiogram (EKG), 12-lead | 11 | $9 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,269
Total received (2018-2024)
Avg $1,324/year across 7 years
Top 6% in TX for family medicine
52
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,221 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,158
2023$1,711
2022$1,431
2021$1,216
2020$857
2019$1,320
2018$1,575
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,215
Novo Nordisk Inc
$1,190
GlaxoSmithKline, LLC.
$930
Amgen Inc.
$893
ABBVIE INC.
$527
AstraZeneca Pharmaceuticals LP
$322
Lilly USA, LLC
$318
AbbVie Inc.
$313
Janssen Pharmaceuticals, Inc
$299
Merck Sharp & Dohme LLC
$240
Allergan Inc.
$228
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Astellas Pharma US Inc
$204
Takeda Pharmaceuticals U.S.A., Inc.
$185
Radius Health, Inc.
$172
Amarin Pharma Inc.
$160
Novartis Pharmaceuticals Corporation
$157
Allergan, Inc.
$154
Teva Pharmaceuticals USA, Inc.
$149
Merck Sharp & Dohme Corporation
$133
SANOFI-AVENTIS U.S. LLC
$109
SHIELD THERAPEUTICS INC
$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$94
ITI, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$73
Bayer HealthCare Pharmaceuticals Inc.
$66
Abbott Laboratories
$55
Avanir Pharmaceuticals, Inc.
$53
Synergy Pharmaceuticals Inc
$48
Kowa Pharmaceuticals America, Inc.
$46
Eisai Inc.
$38
Phathom Pharmaceuticals, Inc.
$37
IDORSIA PHARMACEUTICALS US INC
$37
Biohaven Pharmaceutical Holding Company Ltd.
$36
Horizon Therapeutics plc
$35
Daiichi Sankyo Inc.
$33
Biohaven Pharmaceuticals, Inc.
$32
Exact Sciences Corporation
$31
Ironwood Pharmaceuticals, Inc
$26
Vanda Pharmaceuticals Inc.
$24
Corcept Therapeutics
$24
ARBOR PHARMACEUTICALS, INC.
$23
Antares Pharma, Inc.
$22
Dynavax Technologies Corporation
$20
Nevro Corp.
$20
Tris Pharma Inc
$19
Orexigen Therapeutics, Inc.
$18
Sumitomo Pharma America, Inc.
$17
INOGEN, INC.
$17
GE HEALTHCARE
$14
AbbVie, Inc.
$11
Horizon Pharma plc
$11
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · ANORO · AUSTEDO · Aimovig · Amitiza · Androgel · Austedo XR · BASAGLAR · BELSOMRA · BEXSERO · BREO · BREZTRI · BYSTOLIC · Belviq · CAPLYTA · CELEBREX · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · DUEXIS · DUZALLO · Dayvigo · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GEMTESA · HETLIOZ · Heplisav-B · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Linzess · Livalo · Myrbetriq · NOCDURNA · NUEDEXTA · NURTEC ODT · Omnia · Otezla · Otovel · Ozempic · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Trulance · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in TX.
Equivalent to $107 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
81
Per 100K population
64.9
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lundy is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 6%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lundy experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lundy performed 3,060 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lundy receive payments from pharmaceutical companies?
Yes. Dr. Lundy received a total of $9,269 from 52 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lundy's costs compare to other family medicines in Longview?
Dr. Lundy's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lundy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Longview
Browse family medicines in Longview ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology